StonvexLoading…
StonvexStonvexStonvexCore line items from VMNT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2024 2024-09-30 | Q2 2024 2024-06-30 | Q1 2024 2024-03-31 | Annual 2023 2023-12-31 |
|---|---|---|---|---|
Revenue | $948.57K | $674.97K | $0.00 | $123.06K |
Operating Income | $206.18K | $130.80K | $-100.98K | $-1.47M |
Net Income | $-371.79K | $-243.75K | $-97.19K | $-1.50M |
EPS (Diluted) | Not available | Not available | Not available | $-0.02 |
Total Assets | $203.88K | $395.48K | $154.25K | $10.03K |
Total Liabilities | $9.07M | $9.19M | Not available | $2.37K |
Cash & Equivalents | $21.41K | $7.67K | $57.12K | $0.00 |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 73.44M | 73.44M | 72.47M | 1.00M |